Page last updated: 2024-12-05

2-furoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Furoic acid, also known as pyromucic acid, is a heterocyclic organic compound with the formula C4H3O3. It is a white solid that is soluble in water and organic solvents. 2-Furoic acid is a naturally occurring compound found in plants, including coffee beans and barley. It is also a precursor to other organic compounds, such as furfuryl alcohol and furosemide. 2-Furoic acid has been studied for its potential biological activity, including its antibacterial and anti-inflammatory properties. It has also been investigated for its potential use in the production of pharmaceuticals, pesticides, and other industrial chemicals. The synthesis of 2-furoic acid typically involves the oxidation of furfural, which is a derivative of furfuraldehyde. The importance of 2-furoic acid lies in its versatile nature and its potential applications in various fields, including medicine, agriculture, and industry.'

2-furoic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

furoic acid : A monocarboxylic acid that consists of a furan ring having a single carboxylic acid group on any ring position and derivatives thereof. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

2-furoic acid : A furoic acid having the carboxylic acid group located at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6919
CHEMBL ID1232797
CHEBI ID30845
SCHEMBL ID24446
MeSH IDM0167034

Synonyms (100)

Synonym
nsc-58965
CHEMBL1232797
acido 2-furoico
alpha-furancarboxylic acid
alpha-furoic acid
CHEBI:30845 ,
acide 2-furoique
2-furanoic acid
furan-2-carbonsaeure
furancarboxylic acid
furoic acid
AC-907/25014051
einecs 201-803-0
nsc 8842
brn 0110149
einecs 247-713-5
kyselina pyroslizova [czech]
kyselina 2-furoova [czech]
ccris 2157
ai3-16500
2-furoic acid [per einecs]
.alpha.-furoic acid
nsc8842
2-carboxyfuran
nsc-8842
.alpha.-furancarboxylic acid
furan-2-carboxylic acid
pyromucic acid
88-14-2
2-furancarboxylic acid
2-furoic acid
C01546
inchi=1/c5h4o3/c6-5(7)4-2-1-3-8-4/h1-3h,(h,6,7
2-furoic acid, 98%
STK256918
BMSE000330
F0081
AKOS000119036
NCGC00248301-01
tox21_301128
NCGC00255027-01
dtxcid4021420
dtxsid6041420 ,
cas-88-14-2
BBL009679
26447-28-9
5-18-06-00102 (beilstein handbook reference)
kyselina 2-furoova
kyselina pyroslizova
p577f6494a ,
unii-p577f6494a
FT-0612470
PS-3380
AB00375923-02
S4864
2-furoic acid [mi]
2-furoic acid [usp impurity]
SCHEMBL24446
2-furan carboxylic acid
furanoic acid
2-furanecarboxylic acid
furane-2-carboxylic acid
W-100416
STR01019
furoica
furancarboxylic acid-(2)
mfcd00003238
F9995-1642
2-furoic acid, analytical standard
furic acid
alpha-furancarboxylate
furoate
beta-furancarboxylic acid
beta-furoate
a-furoic acid
b-furancarboxylate
beta-furoic acid
alpha-furoate
a-furoate
2-furanoate
b-furancarboxylic acid
furancarboxylate
a-furancarboxylate
pyromucate
a-furancarboxylic acid
beta-furancarboxylate
b-furoate
b-furoic acid
2-furoic-d3 acid
CS-W013662
HY-W012946
2-furoicacid
Q2210953
CCG-266054
FT-0777874
furancarbonylic acid
WGC36563
EN300-19302
furan-2-carboxylicacid
Z104473462
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
inhibitorA substance that diminishes the rate of a chemical reaction.
human xenobiotic metaboliteAny human metabolite produced by metabolism of a xenobiotic compound in humans.
Saccharomyces cerevisiae metaboliteAny fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
bacterial xenobiotic metaboliteAny bacterial metabolite produced by metabolism of a xenobiotic compound in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
furoic acidA monocarboxylic acid that consists of a furan ring having a single carboxylic acid group on any ring position and derivatives thereof.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID616386Antioxidant activity assessed DPPH scavenging activity at 500 uM2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID616299Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced superoxide anion generation2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID616383Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced elastase release2011Journal of natural products, Sep-23, Volume: 74, Issue:9
Anti-inflammatory principles from Cordyceps sinensis.
AID1624079Inhibition of TEAD (unknown origin) expressed in human HeLa cells up to 150 uM after 6 hrs by nanoluciferase reporter gene assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
AID1624080Cytotoxicity against human HeLa cells assessed as reduction in cell viability by measuring ethidium homodimer-1 uptake up to 150 uM preincubated for 10 mins followed by ethidium homodimer-1 addition measured after 10 mins by fluorescence assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (6.06)18.7374
1990's4 (6.06)18.2507
2000's13 (19.70)29.6817
2010's26 (39.39)24.3611
2020's19 (28.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 56.28

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index56.28 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index5.08 (4.65)
Search Engine Demand Index88.80 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (56.28)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (2.99%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (97.01%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]